<DOC>
	<DOCNO>NCT00599885</DOCNO>
	<brief_summary>People diabetes mellitus prone coronary heart disease , stroke , peripheral vascular disease , diabetes mellitus regard independent risk factor progression coronary artery disease . Several study report diabetes increase risk cardiovascular mortality men woman . With introduction drug-eluting stent ( DESs ) , angiographic rate restenosis later month reduce dramatically several study . However , even DESs , diabetic patient show increased rate restenosis late loss index compare nondiabetic patient . Diabetes consider predictor poor prognosis percutaneous coronary intervention drug-eluting stent . Long-term clinical angiographic outcome percutaneous coronary intervention ( PCI ) drug-metal stent ( DESs ) demonstrate worse diabetic patient compare nondiabetic patient . In era DESs , study compare effect telmisartan valsartan neointima volume intravascular ultrasound ( IVUS ) 8 month zotarolimus-eluting stent implantation hypertensive type 2 diabetic patient . Telmisartan , well-known selective peroxisome proliferator-activated receptor ( PPAR ) -γ activity anti-inflammatory antiproliferative property , could appropriate therapeutic option treat hypertensive diabetic patient significant coronary artery diseases require stent implantation . In contrast , valsartan angiotensin receptor blocker negligible PPAR-γ activity . Increasing interest remain identification systemic pharmacological therapy prevent coronary restenosis especially diabetic patient .</brief_summary>
	<brief_title>Comparison Effects Telmisartan Valsartan Neointima Volume Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Age : 18 year Gender eligible study : Hypertensive diabetic patient either previously diagnose newly find . Systolic blood pressure ≥ 130 mmHg diastolic blood pressure ≥ 80 mmHg newly find hypertensive patient . Fasting blood glucose ≥ 126 mg/dl PP2 blood glucose ≥ 200 mg/dl newly find diabetes . Patients significant de novo coronary artery disease ( diameter stenosis &gt; 70 % ) require stent implantation ( angina pectoris and/or exerciseinduced ischemia ) . Patients informed consent . Acute STsegment elevation myocardial infarction ( MI ) , CTO lesion , leave main lesion Diabetic patient use thiazolidinediones within 3 month Previous history PCI bypass surgery Patients contraindication treatment telmisartan valsartan Pregnant lactating patient Chronic alcohol drug abuse Hepatic dysfunction Renal dysfunction Heart failure ( EF &lt; 50 % ) Expected life expectancy &lt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>